Milos Aleksic, Ph.D.

Senior Director, Drug Discovery at Immunocore Limited

Speaker

Milos Aleksic joined Immunocore in 2010 and currently is leading Drug Discovery department responsible for engineering T cell receptor (TCR) based soluble bispecific ImmTAX molecules for targeting cancer, autoimmune and infection diseases. The main responsibility of the department is discovery of specific wt TCRs, their affinity engineering and production as high affinity bispecific molecules that modulate immune response. Prior to this role, Milos was a postgraduate researcher at University of Oxford where he studied molecular interaction between TCR and pHLA molecules.